PHARMA NEWS

  • Takeda to Establish Joint Venture

    Takeda Pharmaceutical has partnered with PRA Health Sciences, a Raleigh, North Carolina-based contract research organization,...

  • Eisai has entered into a marketing and distribution agreement in China with Orion Corporation, an Espoo, Finland-headquartered,...

  • Janssen Biotech, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (J&J), has expanded its collaboration...

  • Gilead Sells Anti-Addiction Drug

    Gilead Sciences has agreed to sell its aldehyde dehydrogenase 2 (ALDH2) inhibitor, a drug candidate with the potential...

  • Swedish Orphan Biovitrum (Sobi), a Stockholm, Sweden-headquartered specialty healthcare company, has elected to add a...

  • Dr. Reddy’s Laboratories has expanded its commercial operations in Europe with the introduction of its generic drug...

  • Actavis Inc,, part of Teva Pharmaceutical Industries, has issued a Class II voluntarily recall of 499,320 units of glipizide...

  • The US Food and Drug Administration (FDA) has posted a Warning Letter to Sato Pharmaceutical, a Tokyo-headquartered manufacturer...

  • Amgen and Pfizer Lead Pipeline News

    A roundup of the latest market developments from the pipelines of the pharmaceutical majors and other related news, featuring...

  • A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from AstraZeneca, Perrigo,...

  • AstraZeneca and its partner, Valeant Pharmaceuticals, have received US Food and Drug Administration approval for Siliq...

  • AstraZeneca has agreed to license the commercial rights to Zoladex (goserelin acetate implant), a cancer drug, in the...

  • Valeant Pharmaceuticals International has entered into an exclusive, worldwide licensing agreement with EyeGate Pharmaceuticals,...

  • Gilead Sciences has agreed to purchase a Rare Pediatric Disease Priority Review Voucher (PRV) from Sarepta Therapeutics,...

  • GEA, a Dusseldorf, Germany-headquartered engineering group, has been selected by Hanmi Pharmaceutical, a Seoul, South...

  • Lannett, a Philadelphia-headquartered generic drug manufacturer, has announced that it will invest $50 million to expand...

  • The US Food and Drug Administration (FDA) has accepted a biologics license application from Mylan and its partner, Biocon,...

  • Takeda Pharmaceutical has completed its previously announced acquisition of Ariad Pharmaceuticals, headquartered in Cambridge,...

  • West-Ward Pharmaceuticals, a Columbus, Ohio-based generic prescription medication provider and a wholly owned subsidiary...

  • Aurobindo Pharma, a Hyderabad, India-headquartered generics and active pharmaceutical ingredients manufacturer, has acquired...

  • Seattle Genetics, a Bothell, Washington-headquartered biotechnology company, has entered into a development and license...

  • Neurocrine Biosciences, a San Diego-based biopharmaceutical company focused on neurological and endocrine diseases, has...

  • A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Amgen and Lilly....

  • Daiichi Sankyo Group has decided to close its Japanese research subsidiary, Asubio Pharma, based in Kobe, Japan, by the...

  • Allergan has agreed to acquire Zeltiq Aesthetics, a Pleasanton, California-headquartered medical technology company that...

  • Janssen Pharmaceutica, one of the Janssen Pharmaceutical companies of Johnson & Johnson, has entered into an exclusive...

  • Astellas Pharma has announced changes in its top management structure, effective on April 1, 2017 and has formed a division,...

  • Pfizer has announced that it will close its Adelaide, Australia manufacturing plant, which produces the active ingredient...

  • Incyte, a Wilmington, Delaware-based biopharmaceutical company, and Agenus, a Lexington, Massachusetts-based clinical-stage...

  • The United States Court of Appeals for the Federal Circuit has stayed a permanent injunction for Sanofi's and Regeneron...

  • The US Federal Trade Commission (FTC) has filed a civil action in federal district court against Shire ViroPharma, a wholly...

  • Mallinckrodt, a specialty pharmaceutical company has agreed to sell its intrathecal therapy business to Piramal Critical...

  • A roundup of the latest market developments from the pipelines of the pharmaceutical majors and other related news, featuring...

  • A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from BMS, Endo, Merck...

  • Novartis has withdrawn its marketing authorization application (MMA) with the European Medicines Agency (EMA) for its...

  • Allergan has successfully completed the acquisition of LifeCell Corporation, the regenerative medicines business of Acelity,...

  • The Japan Intellectual Property High Court has ruled in favor of Eli Lilly and Company and has confirmed the decisions...

  • Astellas Pharma has executed a license agreement for an exclusive worldwide license to an ear-care program with Auration...

  • Portola Pharmaceuticals, a South San Francisco, California-based biopharmaceutical company focused on the field of thrombosis...

  • Eli Lilly and Company plans to reduce it global research and development (R&D) workforce by 200 positions as part...

  • Teva Appoints Interim CEO

    Teva Pharmaceutical Industries has appointed Dr. Yitzhak Peterburg as interim president and chief executive officer (CEO),...

  • Strides Shasun, a Bangalore, India-headquartered pharmaceutical company, has announced a company restructuring that will...

  • Kyowa Hakko Kirin, a Japan-based pharmaceutical company, has established a subsidiary, Kirin Frontier Co., which will...

  • The European Patent Office (EPO) has upheld a decision that found a patent for Bristol-Myers Squibb’s (BMS) anti-cancer...

  • Biogen has completed the separation of its global hemophilia business into a spin-out company, Bioverativ, which now stands...

  • Sanofi Pasteur, the vaccines unit of Sanofi, has agreed to pay $61.5 million to settle a class-action lawsuit involving...

  • A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Allergan, AstraZeneca,...

  • Teva Pharmaceutical Industries says it plans to appeal a recent court ruling that invalidated four of its patents for...

  • Lek, a Sandoz company and part of Novartis, is investing to expand production of broad-spectrum antibiotics at Novartis’...

  • US President Donald Trump met with pharmaceutical industry executives and representatives from Pharmaceutical Research...

  • Eli Lilly and Company has terminated its $570-million collaboration research and license agreement with Adocia, a Lyon,...

  • H. Lundbeck, a Valby, Denmark-based pharmaceutical company specializing in psychiatric and neurological disorders, has...

  • Immune Pharmaceuticals, a New York-headquartered clinical-stage biopharmaceutical company focused on inflammatory diseases...

  • Beximco Pharmaceuticals, a Dhaka, Bangladesh-headquartered manufacturer of generic pharmaceuticals and active pharmaceutical...

  • Zymeworks Opens R&D Lab for ADCs

    Zymeworks, a Vancouver, Canada-headquartered clinical-stage biopharmaceutical company, has opened a new 10,000-square-foot...

  • Biocon, a Bangalore, India-headquartered biopharmaceuticals company, has been awarded a three-year, Malaysia ringgit 300...

  • The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive...

  • Novo Nordisk has formed a research collaboration with the University of Oxford in the UK for the development of Type...

  • Incyte, a Wilmington, Delaware-based biopharmaceutical company, has formed a collaboration and license agreement with...

  • Mylan has issued a voluntarily Class II recall of four dosage forms of temozolomide capsules, a chemotherapy brain-tumor...

  • Pfizer Leads Pipeline News

    A roundup of the latest market developments from the pipelines of the pharmaceutical majors and other related news, featuring...

  • Adma Biologics, a Ramsey, New Jersey-based late-stage biopharmaceutical company focused on specialty plasma-based biologics,...

  • Takeda Pharmaceutical has signed an exclusive licensing agreement with Exelixis, a South San Francisco, California-based...

  • Johnson & Johnson (J&J) has agreed to acquire Actelion, an Allschwil, Switzerland-based biopharmaceutical company,...

  • Endo International has initiated a restructuring program that primarily impacts the company’s corporate functions...

  • Celgene, a Summit, New Jersey-based biopharmaceutical company, has agreed to acquire Delinia, a privately held biotechnology...

  • Bristol-Myers Squibb (BMS) and its partner, Ono Pharmaceutical Company, headquartered in Osaka, Japan, have signed a global...

  • Takeda Pharmaceutical has formed a global collaboration with Ovid Therapeutics, a privately held New York-based biopharmaceutical...

  • Takeda Pharmaceutical has begun a cash tender offer, through its wholly owned indirect subsidiary, Kiku Merger, for all...

  • Perrigo has issued a voluntary Class II recall of 162,534 tubes of clindamycin phosphate and benzoyl peroxide gel, a prescription...

  • A roundup of the latest market developments from the pipelines of the pharmaceutical majors and other related news, featuring...

  • A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from AbbVie, Allergan,...

  • Boehringer Ingelheim, on behalf of its diabetes alliance with Eli Lilly and Company, has entered into an agreement with...

  • Merck KGaA has signed a collaboration and license agreement with Domain Therapeutics, a biopharmaceutical company headquartered...

  • Both the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have accepted for review Boehringer...

  • Valeant Pharmaceuticals has agreed to sell all of the outstanding equity interests in Dendreon Pharmaceuticals, headquartered...

  • The Bill & Melinda Gates Foundation, the Wellcome Trust, and the governments of Germany, Japan, and Norway have pledged...

  • Generex Biotechnology, based in Toronto, has signed a letter of intent to acquire a controlling equity interest in Emmaus...

  • Eli Lilly and Company plans to cut 485 sales positions across its operations in the US, including its US Bio-Medicines...

  • Endo International, a specialty pharmaceutical and generic-drug company, and the US Federal Trade Commission (FTC) have...

  • Eli Lilly and Company has agreed to acquire CoLucid Pharmaceuticals, a Cambridge, Massachusetts-based biopharmaceutical...

  • GlaxoSmithKline (GSK) has appointed Luke Miels as the new president of its Global Pharmaceuticals business with the upcoming...

  • Eisai, Chugai Pharmaceutical, and Roche have agreed that Eisai will acquire the manufacturing rights in Japan for the...

  • Astellas Terminates Vaccines Pact

    Astellas Pharma has terminated an agreement that was executed in September 2010 between it and UMN Pharma, a pharmaceutical...

  • Takeda Partners in ADCs

    Takeda Pharmaceutical has entered into a research licensing agreement with LegoChem Biosciences (LCB), a biopharmaceutical...

  • Takeda Pharmaceutical has formed a five-year collaboration with Maverick Therapeutics, a Brisbane, California-based private...

  • Amgen in Anemia Drug Supply Pact

    Amgen has entered into a new six-year sourcing and supply agreement with DaVita, a kidney-care company based in Denver,...

  • Eli Lilly and Company has expanded an existing immuno-oncology collaboration with Merck & Co., through a subsidiary,...

  • Merck KGaA has entered into a licensing agreement with Vertex Pharmaceuticals, a Boston-based biotechnology company, for...

  • A roundup of the latest market developments from the pipelines of the pharmaceutical majors and other related news, featuring...

  • Perrigo Changes Reporting Structure

    Perrigo has changed its reporting segments to better align with the company's organizational structure. Beginning with...

  • Gilead Leads Drug Approval News

    A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Gilead. Editor's...

  • Eli Lilly and Company has received a favorable ruling from the US Court of Appeals for the Federal Circuit, which upheld...

  • Merck KGaA Partners in Big Data

    Merck KGaA has partnered with Palantir Technologies, a developer of data integration and analysis software headquartered...

  • AbbVie has formed a collaboration with Zebra Biologics, an emerging preclinical-stage biotechnology company headquartered...

  • Aurobindo Pharma, a generics and active pharmaceutical ingredients (API) manufacturer headquartered in Hyderabad, India...

  • Aerie Pharmaceuticals, an Irvine, California-headquartered clinical-stage pharmaceutical company focused on glaucoma and...

  • Merck KGaA has appointed Joachim Christ as its new chief procurement officer (CPO), succeeding Friedhelm Felten in that...

  • Biogen has agreed to a settlement and license agreement with Forward Pharma, a Copenhagen, Denmark-headquartered biopharmaceutical...

  • Pfizer Saudi Limited, a subsidiary of Pfizer, has opened a manufacturing facility in King Abdullah Economic City (KAEC),...

  • Amgen has boosted its pain-drug portfolio by signing a deal with SiteOne Therapeutics, a pharmaceutical company headquartered...

  • Amgen has been granted a permanent injunction by the United States District Court in Delaware that prohibits Sanofi and...

  • Sanofi has extended its cardiomyopathy research collaboration with MyoKardia, a clinical-stage biopharmaceutical company...

  • BMS, Janssen in Immunotherapy Pact

    Bristol-Myers Squibb (BMS) has formed a new clinical research collaboration with Janssen Biotech, a Johnson & Johnson...

  • Novartis has formed a collaboration and option agreement with Ionis Pharmaceuticals, a Carlsbad, California-based pharmaceutical...

  • Takeda Pharmaceutical has entered into an agreement with PvP Biologics, a San Diego-headquartered biopharmaceutical company,...

  • Pfizer has formed a collaboration with AbCellera Biologics, a privately held biotechnology company headquartered in Vancouver,...

  • Eisai, with its US pharmaceutical subsidiary Eisai Inc., has revised an agreement with Arena Pharmaceuticals, a San Diego-based...

  • AstraZeneca has entered into an agreement with APT Therapeutics, a privately held biopharmaceutical company headquartered...

  • Shire has sold its MRT platform, which is an mRNA-based therapy platform developed by its subsidiaries, to RaNA Therapeutics,...

  • Takeda Pharmaceutical has agreed to acquire Ariad Pharmaceuticals, headquartered in Cambridge, Massachusetts, for $24...

  • Merrimack Pharmaceuticals, headquartered in Cambridge, Massachusetts, has agreed to sell two oncology drugs to Ipsen,...

  • EMD Serono, the biopharmaceutical business of Merck KGaA, has formed a three-year strategic collaboration with The University...

  • AbbVie has formed four new collaborations and investments with healthcare innovators to advance early-stage research in...

  • Sanofi has signed an agreement with ImmuNext, a biopharmaceutical company headquartered in Lebanon, New Hampshire, to...

  • Allergan has entered two deals, one for gastrointestinal (GI) drug development and another for development of drugs to...

  • Amgen has formed a research collaboration and license agreement with Immatics Biotechnologies, a clinical-stage biopharmaceutical...

  • Celgene Switzerland, an affiliate of Celgene, has formed a research collaboration with Anokion, a privately held biopharmaceutical...

  • Mylan to Acquire OTC Cold Remedy

    Mylan has agreed to acquire global rights to the Cold-EEZE brand cold remedy line from ProPhase Labs, a Doylsetown, Pennsylvania-based...

  • Teva Pharmaceutical Industries has completed the previously announced sale of the majority of the assets and operations...

  • Merck & Co. has decided to advance a clinical development program for which it is partnered with Incyte Corporation,...

  • Daiichi Sankyo has formed a partnership in Japan with Kite Pharma, a clinical-stage biopharmaceutical company headquartered...

  • Kite Pharma, a clinical-stage biopharmaceutical company headquartered in Santa Monica, California, and Shanghai Fosun...

  • Eli Lilly and Company has made a series of changes to its commercial organization and leadership structure. The moves...

  • Sanofi and Boehringer Ingelheim (BI) have closed on their previously announced multi-billion dollar business-swap transaction...

  • Sanofi and its vaccines global business unit, Sanofi Pasteur, have confirmed that they ended their vaccine joint-venture,...

  • Impax Laboratories, a Hayward, California-based specialty pharmaceutical company focused on controlled-release and specialty...

  • GlaxoSmithKline (GSK) has terminated its collaboration in Sub-Saharan Africa with Aspen Pharmacare Holdings, a pharmaceutical...

  • Genentech Names New CEO

    Genentech, a member of the Roche Group, has appointed Bill Anderson to chief executive officer, effective January 1, 2017....

  • BMS Appoints New Board Chairman

    Bristol-Myers Squibb’s (BMS’) board of directors has appointed Giovanni Caforio, MD, as chairman of the board,...

  • Biogen Appoints New CEO

    Biogen’s board of directors has appointed Michel Vounatsos as chief executive officer and member of the board of...

  • Novartis has agreed to acquire Ziarco Group, a Kent, England-based privately held clinical-stage biotechnology company...

  • A roundup of the latest market developments from the pipelines of the pharmaceutical majors and other related news, featuring...

  • Takeda Pharmaceutical has agreed to sell its laboratory reagents business, Wako Pure Chemical Industries, to Fujifilm...

  • A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Gilead, Eli Lilly...

  • Celgene has formed a collaboration with Evotec, a Hamburg, Germany-based drug-discovery company, to identify disease-modifying...

  • Pfizer and Bristol-Myers Squibb (BMS) have signed agreements in which each company will loan $25 million to Portola Pharmaceuticals,...

  • Bristol-Myers Squibb (BMS) has entered into an agreement with PsiOxus Therapeutics, an immuno-oncolytic virus company...

  • Novartis in Liver-Disease Drug Pact

    Novartis has entered into an exclusive option, collaboration and license agreement with Conatus Pharmaceuticals, a San...

  • Allergan has agreed to acquire the LifeCell regenerative medicines business of Acelity, a San Antonio, Texas-headquartered...

  • Novartis to Acquire Eye Drug Company

    Novartis has agreed to acquire the eye-drug company, Encore Vision, a privately held firm in Fort Worth, Texas focused...

  • Bristol-Myers Squibb has formed a clinical-trial collaboration with Calithera Biosciences, a clinical-stage biotechnology...

  • Otsuka Pharmaceutical has entered into a collaboration and license agreement in the US with Akebia Therapeutics, a biopharmaceutical...

  • Novartis has entered into an exclusive license agreement with Sunovion Pharmaceuticals, a biopharmaceutical company headquartered...

  • Novartis has entered into global license and supply agreements with Ligand Pharmaceuticals, a biopharmaceutical company...

  • J&J Back in Talks with Actelion

    Johnson & Johnson has confirmed that it has entered into exclusive negotiations with Actelion, an Allschwil, Switzerland-based...

  • Eisai has formed a joint research agreement with Keio University, located in Tokyo, to discover and develop new drugs...

  • Celgene has formed a collaboration with Triphase Accelerator , a privately held drug development company headquartered...

  • Biogen’s board of directors has approved the planned spin-off of its hemophilia business, Bioverativ Inc., and declared...

  • Astellas Pharma has completed the acquisition of Ganymed Pharmaceuticals, a biopharmaceutical company located in Mainz,...

  • Pfizer has completed its previously announced acquisition of AstraZeneca’s late-stage small molecule anti-infective...

  • Baxter International has agreed to acquire Claris Injectables, a generic injectables pharmaceutical company based in Ahmedabad,...

  • Bayer has cleared one hurdle in its proposed $66 billion acquisition of Monsanto, an agrochemical and seed company, with...

  • AstraZeneca and Eli Lilly and Company have entered a worldwide agreement to co-develop MEDI1814, an antibody selective...

  • Endo International has entered into an agreement with its partner, BioDelivery Sciences International (BDSI), a Raleigh,...

  • Spark Therapeutics, a Philadelphia-based late clinical-stage gene therapy company, has entered into a license agreement...

  • Perrigo has announced its intention to restructure the Branded Consumer Healthcare's Omega Pharma Belgium business, which...

  • A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from AbbVie, Novartis,...

  • Johnson & Johnson (J&J) has confirmed that it has ended discussions with Actelion Pharmaceuticals, an Allschwil,...

  • A roundup of the latest market developments from the pipelines of the pharmaceutical majors and other related news, featuring...

  • Mylan has been granted review of patents for Allergan’s blockbuster eye-care drug, Restasis (cyclosporine ophthalmic...

  • Perrigo has agreed to sell its entire shareholding in Perrigo API India to Strides Shasun, a Bangalore, India-based pharmaceutical...

  • Bayer and Versant Ventures, a San Francisco-based healthcare investment firm, have launched BlueRock Therapeutics, a regenerative...

  • Swedish Orphan Biovitrum (Sobi), a specialty healthcare company headquartered in Stockholm, Sweden, has entered into a...

  • Purdue Pharma, a Stamford, Connecticut-based pharmaceutical company, has signed a research collaboration, option, and...

  • Sanofi has announced an approximate 20% reduction in staff at its US diabetes and cardiovascular business unit as part...

  • GlaxoSmithKline (GSK) has opened a new global vaccines research and development (R&D) center in Rockville, Maryland...

  • Almirall, a Barcelona-based provider of medicines and medical devices, has formed a collaboration with Nuevolution A/S,...

  • Astellas Pharma’s Astellas Pharma Europe business has agreed to transfer the exclusive rights for its pain medication,...

  • Bristol-Myers Squibb (BMS) has announced that it will make investments to support its biologics initiatives. The company...

  • AstraZeneca has announced that it will eliminate 700 positions across its US commercial business, including the company’s...

  • Mylan has announced plans for restructuring programs in certain locations representing initial steps in a series of actions...

  • Editor's note: this story was updated on December 8, 2016 to include further details and background. Shire has received...

  • Teva Pharmaceutical Industries has named Dipankar Bhattacharjee president and chief executive officer (CEO), Global Generic...

  • AstraZeneca has completed its previously announced agreement to divest the rights to Rhinocort Aqua (budesonide) nasal...

  • Celgene has agreed to acquire Acetylon Pharmaceuticals, a Boston-based company specializing in cancer therapeutics. Prior...

  • Takeda Pharmaceutical and Lightstone Ventures, a Menlo Park, California-based investment firm, have launched a new neuroscience-focused...

  • Pfizer has formed a collaboration with IBM Watson Health that will use the Watson for Drug Discovery cloud-based cognitive...

  • Sanofi has formed an alliance with JHL Biotech, a Taiwan-based biopharmaceutical company, to develop and commercialize...

  • AbbVie has signed five-year research and discovery (R&D) agreements each with Johns Hopkins University School of Medicine...

  • A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Endo, Eli Lilly...

  • A roundup of the latest market developments from the pipelines of the pharmaceutical majors and other related news, featuring...

  • GlaxoSmithKline (GSK) has appointed Deborah Waterhouse the chief executive officer (CEO) designate of ViiV Healthcare,...